Physician profile
Wesley Klir
NPI 1902883234
$6,532.42
in general payments reported to CMS, 2019-2025
32 companies · $916 in 2025
The $916 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,523 · 2020: $617 · 2021: $323 · 2022: $905 · 2023: $1,000 · 2024: $1,249 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,165.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $994.93 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $853.13 | 2021-2025 | |
| Pfizer INC. | $801.25 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $702.34 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $595.09 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $370.41 | 2019-2024 | Prolia, Evenity, Repatha |
| Merck Sharp & Dohme LLC | $363.87 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Novartis Pharmaceuticals Corporation | $253.58 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $213.15 | 2019-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $213.07 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.06 | 2019-2025 | Jardiance |
| Sumitomo Pharma America, INC. | $150.32 | 2023-2025 | Gemtesa |
| Sanofi-Aventis U.S. LLC | $147.79 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $78.72 | 2023-2025 | Rexulti |
| Sanofi Pasteur INC. | $77.68 | 2020-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $68.03 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Phathom Pharmaceuticals, INC. | $60.92 | 2024-2025 | Voquezna |
| Astellas Pharma US INC | $58.56 | 2019-2024 | Veozah |
| Amarin Pharma, INC. | $52.87 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.60 | 2019-2023 | Cuvitru |
| Kowa Pharmaceuticals America, INC. | $36.98 | 2019-2021 | |
| Glaxosmithkline, LLC. | $24.64 | 2019 | |
| Abbott Laboratories | $23.08 | 2024 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $23.00 | 2022 | |
| Dexcom, INC. | $17.61 | 2025 | Dexcom G6 Transmitter |
| Vbi Vaccine (Delaware) INC. | $16.90 | 2023 | Prehevbrio |
| Alnylam Pharmaceuticals INC. | $16.34 | 2023 | Onpattro |
| Daiichi Sankyo INC. | $16.08 | 2020 | |
| Currax Pharmaceuticals LLC | $15.99 | 2024 | Contrave |
| Allergan, INC. | $15.74 | 2020 | |
| Alkermes, INC. | $14.69 | 2023 | Aristada, Lybalvi |
| Lucid Diagnostics INC. | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Klir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.